Efficacy and outcome predictors of gonadotropin treatment for male congenital hypogonadotropic hypogonadism: A retrospective study of 223 patients

Medicine (United States)

Volumn 95, Issue 9, 2016, Pages

  Liu, Zhaoxiang ^a   Mao, Jangfeng ^a   Wu, Xueyan ^a   Xu, Hongli ^a   Wang, Xi ^a   Huang, Bingkun ^a   Zheng, Junjie ^a   Nie, Min ^a   Zhang, Hongbing ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; HYPOPHYSIS HORMONE; TESTOSTERONE;

ACNE; ADULT; ARTICLE; AZOOSPERMIA; CONGENITAL HYPOGONADOTROPIC HYPOGONADISM; DRUG EFFICACY; FOLLOW UP; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPERMATOGENESIS; SPERMATOZOON MOTILITY; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; COMBINATION DRUG THERAPY; DRUG EFFECTS; HYPOGONADISM; YOUNG ADULT;

CHORIONIC GONADOTROPIN; DRUG THERAPY, COMBINATION; HUMANS; HYPOGONADISM; MALE; MENOTROPINS; RETROSPECTIVE STUDIES; SPERMATOGENESIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84962592224     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000002867     Document Type: Article

References (29)

1. Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). 2013;68(Suppl 1):81-88.
2. Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism-pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547-564.
3. Farhat R, Al-zidjali F, Alzahrani AS. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary. 2010;13:105-110.
4. Dwyer AA, Raivio T, Pitteloud N. Gonadotrophin replacement for induction of fertility in hypogonadal men. Best Pract Res Clin Endocrinol Metab. 2015;29:91-103.
5. Liu PY, Baker HW, Jayadev V, et al. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009;94:801-808.
6. Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: A 30-year retrospective study. J Urol. 2005;173:2072-2075.
7. Ishikawa T, Ooba T, Kondo Y, et al. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril. 2007;88:1697-1699.
8. Warne DW, Decosterd G, Okada H, et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril. 2009;92:594-604.
9. Rastrelli G, Corona G, Mannucci E, et al. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: A metaanalytic study. Andrology-US. 2014;2:794-808.
10. Yang L, Zhang SX, Dong Q, et al. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int Urol Nephrol. 2012;44:393-399.
11. Raivio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863-873.
12. WHO. Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva: World Health Organization; 2010.
13. Rao M, Meng TQ, Hu SH, et al. Evaluation of semen quality in 1808 university students, from Wuhan, Central China. Asian J Androl. 2015;17:111-116.
14. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231-245.
15. Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic, hypogonadism., European Metrodin HP Study Group. Fertil Steril. 1998;70:256-262.
16. Bouloux P, Warne DW, Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil Steril. 2002;77: 270-273.
17. Matsumoto AM, Snyder PJ, Bhasin S, et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril. 2009;92:979-990.
18. Bouvattier C, Maione L, Bouligand J, et al. Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2012;8:172-182.
19. Biffoni M, Marcucci I, Ythier A, et al. Effects of urinary gonadotrophin preparations on human in-vitro immune function. Hum Reprod. 1998;13:2430-2434.
20. Hadziselimovic NO, de Geyter C, Demougin P, et al. Decreased expression of FGFR1, SOS1, RAF1 genes in cryptorchidism. Urol Int. 2010;84:353-361.
21. Cotton L, Gibbs GM, Sanchez-Partida LG, et al. FGFR-1 [corrected] signaling is involved in spermiogenesis and sperm capacitation. J Cell Sci. 2006;119(Pt 1):75-84.
22. Salenave S, Chanson P, Bry H, et al. Kallmann's syndrome: A comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab. 2008;93:758-763.
23. Nishio H, Mizuno K, Moritoki Y, et al. Clinical features and testicular morphology in patients with Kallmann syndrome. Urology. 2012;79:684-686.
24. Trsinar B, Muravec UR. Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism. World J Urol. 2009;27:513-519.
25. Liu PY, Gebski VJ, Turner L, et al. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod. 2002;17: 625-633.
26. Fuse H, Akashi T, Kazama T, et al. Gonadotropin therapy in males with hypogonadotropic hypogonadism: factors affecting induction of spermatogenesis after gonadotropin replacement. Int Urol Nephrol. 1996;28:367-374.
27. Gray RH, Wu LY. Subfertility and risk of spontaneous abortion. Am J Public Health. 2000;90:1452-1454.
28. Modvig J, Schmidt L, Damsgaard MT. Measurement of total risk of spontaneous abortion: The virtue of conditional risk estimation. Am J Epidemiol. 1990;132:1021-1038.
29. Sykiotis GP, Hoang XH, Avbelj M, et al. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010;95:3019-3027.